Literature DB >> 35089485

Age-dependent aggregation of α-synuclein in the nervous system of gut-brain axis is associated with caspase-1 activation.

Qi Hu1, Mei Hong2,3,4, Mengyang Huang5, Quan Gong6,7, Xiaofan Zhang8, Vladimir N Uversky9,10, Francisco Pan-Montojo11, Teng Huang1, Honglian Zhou1, Suiqiang Zhu12.   

Abstract

α-Synuclein (α-Syn) plays a key role in the development of Parkinson' desease (PD). As aging is acknowledged to be the greatest risk factor for PD, here we investigated α-Syn expression in the ileum, thoracic spinal cord, and midbrain of young (1-month-old), middle-aged (6-, 12-month-old) to old (18-month-old) mice. We demonstrated that both the levels of α-Syn monomers, oligomers and ratios of oligomers to monomers were increased with aging in the ileum, thoracic spinal cord, and midbrain. Whereas, the expression of tyrosine hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis, was decreased with aging in the midbrain. We failed to find corresponding α-Syn mRNA increase with aging. However, we found an increased expression of caspase-1 in the ileum, thoracic spinal cord, and midbrain. A specific caspase-1 inhibitor VX765 significantly reduced levels of both the α-Syn monomers and oligomers triggered by the rotenone in vitro. Taken together, the increase in α-Syn aggregation with aging might not occur first in the gut, but simultaneously in the nervous system of gut-brain axis. The mechanism of the age-dependent aggregation of α-Syn in nervous system is likely triggered by the aging-related caspase-1 activation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aging; Caspase-1; Parkinson’ desease; Rotenone; α-Synuclein

Mesh:

Substances:

Year:  2022        PMID: 35089485     DOI: 10.1007/s11011-022-00917-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.655


  52 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

Review 2.  Building a second brain in the bowel.

Authors:  Marina Avetisyan; Ellen Merrick Schill; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

3.  Expression of alpha-synuclein in different brain parts of adult and aged rats.

Authors:  A Adamczyk; J Solecka; J B Strosznajder
Journal:  J Physiol Pharmacol       Date:  2005-03       Impact factor: 3.011

4.  Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2006-10-18       Impact factor: 5.996

Review 5.  Α-synuclein misfolding and Parkinson's disease.

Authors:  Leonid Breydo; Jessica W Wu; Vladimir N Uversky
Journal:  Biochim Biophys Acta       Date:  2011-10-12

6.  Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.

Authors:  Silke Appel-Cresswell; Carles Vilarino-Guell; Mary Encarnacion; Holly Sherman; Irene Yu; Brinda Shah; David Weir; Christina Thompson; Chelsea Szu-Tu; Joanne Trinh; Jan O Aasly; Alex Rajput; Ali H Rajput; A Jon Stoessl; Matthew J Farrer
Journal:  Mov Disord       Date:  2013-03-01       Impact factor: 10.338

7.  Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease.

Authors:  Laura Brighina; Alessandro Prigione; Barbara Begni; Alessio Galbussera; Simona Andreoni; Roberto Piolti; Carlo Ferrarese
Journal:  Neurobiol Aging       Date:  2008-08-03       Impact factor: 4.673

8.  Prevalence of parkinsonian signs and associated mortality in a community population of older people.

Authors:  D A Bennett; L A Beckett; A M Murray; K M Shannon; C G Goetz; D M Pilgrim; D A Evans
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

9.  Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.

Authors:  Fares Bassil; Pierre-Olivier Fernagut; Erwan Bezard; Alain Pruvost; Thierry Leste-Lasserre; Quyen Q Hoang; Dagmar Ringe; Gregory A Petsko; Wassilios G Meissner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

10.  Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate.

Authors:  Marie-Hélène Canron; Martine Perret; Anne Vital; Erwan Bézard; Benjamin Dehay
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

View more
  2 in total

Review 1.  Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment.

Authors:  Xian Wu; Teng Wan; Xiaoyu Gao; Mingyuan Fu; Yunfeng Duan; Xiangru Shen; Weiming Guo
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

Review 2.  Oligomeropathies, inflammation and prion protein binding.

Authors:  Gianluigi Forloni; Pietro La Vitola; Claudia Balducci
Journal:  Front Neurosci       Date:  2022-08-23       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.